Ken Herrmann MD, MBA

Prof. Dr Ken Herrmann is a Professor of Nuclear Medicine at the University of Medicine Essen, Essen, Germany, and until recently acted as an Adjunct Professor at the Ahmanson Translational Imaging Division of the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles (UCLA), Los Angeles, California, USA.

In 2011, he completed his residency in nuclear medicine at Klinikum rechts der Isar, Technische Universität München, Munich, Germany, focusing on his research entitled “In Vivo Proliferation Imaging with 3´deoxy-3´-[18F]Fluorothymidine PET in Oncology”. Following this, Prof. Dr Herrmann then went on to complete a fellowship at Hokkaido University, Hokkaido, Japan and received an executive MBA degree from the University of Zürich, Zürich, Switzerland. From 2012 to 2016, he served as Vice Chair of the Department of Nuclear Medicine at Universitätsklinikum Würzburg, Würzburg, Germany. He served as Chair of the European Association of Nuclear Medicine (EANM) Oncology & Theranostics Committee from 2020-2023.

Presently, he is the Section Editor of The Journal of Nuclear Medicine and of Cancer Imaging. He has also authored more than 600 peer-reviewed articles.